Abeona Therapeutics (ABEO) Debt Ratio (2010 - 2026)

Abeona Therapeutics' Debt Ratio history runs 14 years deep, the most recent figure standing at 0.09 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 53.05% year-over-year to 0.09 in Q1 2026; TTM through Mar 2026 was 0.09, a 53.05% decrease from a year earlier, with the FY2025 full-year figure at 0.09, down 47.58% from the prior year.
• Debt Ratio steadied at 0.09 in Q1 2026 per ABEO's latest filing, from 0.09 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.3 in Q1 2024 and bottomed at 0.06 in Q4 2022.
• The 5-year median for Debt Ratio is 0.15 (2024), against an average of 0.15.
• Across the five-year window, Debt Ratio jumped 1367.55% in 2022 and sank 53.05% in 2026, its largest moves.
• Year by year, Debt Ratio stood at 0.06 in 2022, then gained by 10.38% to 0.07 in 2023, then surged by 143.27% to 0.17 in 2024, then sank by 47.58% to 0.09 in 2025, then retreated by 0.14% to 0.09 in 2026.
• Per Business Quant, the three latest ABEO Debt Ratio figures stand at 0.09 (Q1 2026), 0.09 (Q4 2025), and 0.09 (Q3 2025).